SciELO - Scientific Electronic Library Online

vol.31 issue10Prostate biopsy strategies: A review of the literatureSteroid and Xenobiotic Receptor (SXR), Multidrug Resistance Gene (MDR1) and GSTs, SULTs AND CYP polymorphism expression in invasive bladder cancer, analysis of their expression and correlation with other prognostic factors author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Actas Urológicas Españolas

Print version ISSN 0210-4806


ALVAREZ-MUGICA, M. et al. Use of zoledromic acid on pain control in stages M1b of prostate cancer. Actas Urol Esp [online]. 2007, vol.31, n.10, pp.1100-1106. ISSN 0210-4806.

Objectives: To probe the use of Zoledromic acid in the control of the pain due to bone methastasis of a prostate cancer. Material and method: We included in our study 37 consecutive patients diagnosed of prostate cancer who developed bone methastasis during 2005 and 2006 to whom we gave a 4 mg dose of Zoledromic acid during a mean time of 10.24 months. Results: We observed a complete control of the pain in 8 of the 20 patients, and partially in 6 of those patients. We did not evaluate any adverse reaction due to this treatment. Conclusions: We still yet to know whether the administration of this treatment in the early stages of the prostate cancer could prevent or retard the appearance of bone methastasis.

Keywords : Zoledromic acid; Bone methastasis; Bone pain.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License